Oncternal Therapeutics, Inc.

Pharmaceutical company · San Diego, California, United States

Oncternal Therapeutics, Inc. is a pharmaceutical company headquartered in San Diego, California, United States. Its earliest recorded incorporation is in 2013. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $4.3 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $6.5 million sold in a notice filed in 2020.

www.oncternal.comProfile compiled from public records. Is this your company? Request a correction or update

Oncternal Therapeutics at a glance

Typepharmaceutical company
HeadquartersSan Diego, California, United States
Earliest incorporation on record2013
SEC industryPharmaceutical Preparations
Employees (per SBIR records)29

What does Oncternal Therapeutics do?

US government research funding

5 SBIR/STTR small-business research awards from US health agencies, $4.3 million in total (2003 to 2023). NIH funding came from the National Institute of Neurological Disorders and Stroke, National Cancer Institute.

Private fundraising reported to the SEC

19 Form D notices; the most recent reported $6.5 million sold (2020).

Frequently asked questions about Oncternal Therapeutics

Where is Oncternal Therapeutics headquartered?

Oncternal Therapeutics, Inc. is headquartered in San Diego, California, United States.

What does Oncternal Therapeutics do?

Oncternal Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

When was Oncternal Therapeutics founded?

The earliest incorporation on record for Oncternal Therapeutics, Inc. is in 2013, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.